Cytosine arabinoside induced liver damage: Histopathologic demonstration
- 1 January 1983
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 11 (4) , 287-290
- https://doi.org/10.1002/mpo.2950110416
Abstract
Two patients with acute leukemia developed abnormal liver function tests after the administration of cytosine arabinoside. Other possibles causes for such abnormalities were not likely. In both patients a close chronologic relationship between the administration of the drug and the appearance of the laboratory abnormalities was noted. The liver damage was also documented by biopsy. To our knowledge this is the first time that the hepatotoxic effects of cytosine arabinoside are histologically demonstrated.Keywords
This publication has 14 references indexed in Scilit:
- Antineoplastic agents and the liverGastroenterology, 1980
- Advances in the Treatment of Acute Myelogenous LeukemiaNew England Journal of Medicine, 1979
- Nystatin Prophylaxis in Leukemia and LymphomaNew England Journal of Medicine, 1978
- Liver disease complicating the management of acute leukemia during remissionCancer, 1978
- Hyperbilirubinemia during induction therapy of acute granulocytic leukemiaCancer, 1977
- Veno-Occlusive Disease of the Liver After Chemotherapy of Acute LeukemiaAnnals of Internal Medicine, 1976
- Cytarabine for Herpesvirus InfectionsJAMA, 1972
- Cytosine arabinoside in acute granulocytic leukemiaClinical Pharmacology & Therapeutics, 1971
- Cytosine arabinoside in acute leukemia of childhoodCancer, 1971
- Prolonged infusion of arabinosyl cytosine in childhood leukemiaCancer, 1970